Eaton Vance Management Gsk PLC Transaction History

Eaton Vance Management

$67.5 Billion
Q3 2022

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$42.05 - $47.77 $247,338 - $280,983	-5,882 Reduced 6.73%	81,457 $3.55 Million
Q1 2022 May 16, 2022	BUY	$40.23 - $47.74 $18,747 - $22,246	466 Added 0.54%	87,339 $3.81 Million
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $23,444 - $27,321	603 Added 0.7%	86,873 $3.54 Million
Q3 2021 Nov 15, 2021	SELL	$38.79 - $43.16 $96,431 - $107,295	-2,486 Reduced 2.8%	86,270 $3.06 Million
Q2 2021 Aug 16, 2021	BUY	$36.52 - $41.46 $72,053 - $81,800	1,973 Added 2.27%	88,756 $3.54 Million
Q1 2021 May 17, 2021	SELL	$34.27 - $40.01 $357,847 - $417,784	-10,442 Reduced 10.74%	86,783 $3.1 Million
Q4 2020 Feb 12, 2021	SELL	$34.07 - $39.94 $30.4 Million - $35.7 Million	-892,689 Reduced 90.18%	97,225 $3.58 Million
Q3 2020 Nov 13, 2020	SELL	$38.11 - $42.99 $1.05 Million - $1.19 Million	-27,578 Reduced 2.71%	989,914 $37.3 Million
Q2 2020 Nov 20, 2020	SELL	$37.87 - $43.58 $1.73 Million - $1.99 Million	-45,678 Reduced 4.3%	1,017,492 $41.5 Million
Q2 2020 Aug 13, 2020	SELL	$37.87 - $43.58 $12.3 Million - $14.2 Million	-325,162 Reduced 23.42%	1,063,170 $43.3 Million
Q1 2020 May 14, 2020	SELL	$32.47 - $48.83 $15.2 Million - $22.8 Million	-467,497 Reduced 25.19%	1,388,332 $53 Million
Q4 2019 Feb 11, 2020	SELL	$42.0 - $48.25 $3.99 Million - $4.59 Million	-95,119 Reduced 4.88%	1,855,829 $87.2 Million
Q3 2019 Nov 14, 2019	SELL	$40.46 - $43.52 $12.1 Million - $13.1 Million	-300,222 Reduced 13.34%	1,950,948 $83.3 Million
Q2 2019 Nov 21, 2019	BUY	$39.4 - $42.7 $854,980 - $926,590	21,700 Added 0.97%	2,251,170 $90.1 Million
Q2 2019 Aug 16, 2019	BUY	$39.4 - $42.7 $5.57 Million - $6.03 Million	141,256 Added 6.76%	2,229,470 $89 Million
Q1 2019 May 14, 2019	BUY	$38.57 - $42.69 $5.44 Million - $6.02 Million	141,086 Added 7.25%	2,088,214 $87.3 Million
Q4 2018 Feb 07, 2019	BUY	$37.8 - $42.69 $1.15 Million - $1.3 Million	30,357 Added 1.58%	1,947,128 $74.4 Million
Q3 2018 Nov 13, 2018	BUY	$39.75 - $42.69 $25.2 Million - $27 Million	633,093 Added 49.32%	1,916,771 $77 Million
Q2 2018 Aug 10, 2018	BUY	$39.61 - $42.76 $47.9 Million - $51.7 Million	1,208,800 Added 1614.36%	1,283,678 $51.7 Million
Q1 2018 May 07, 2018	BUY	$36.18 - $40.15 $20,007 - $22,202	553 Added 0.74%	74,878 $2.93 Million
Q4 2017 Feb 12, 2018	SELL	$35.34 - $41.9 $6,926 - $8,212	-196 Reduced 0.26%	74,325 $2.64 Million
Q3 2017 Nov 13, 2017	BUY	$39.44 - $41.55 $2.94 Million - $3.1 Million	74,521	74,521 $3.03 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Account